Prompt, secure access to full statements:
Plan a virtual visit with a provider through your PC or mobile device:
Securely connects you to portions of your medical record:
Online second opinions from top specialists:
Securely request a copy of your Images Studies from our Images Library:
Physician-to-physician medical record access:
Medical record system for physicians in private practice:
Find phone numbers and email addresses for Cleveland Clinic Online Services:
Our award-winning blog brings you insights on health, nutrition and wellness from experts you can trust. Enjoy recipes, videos, infographics and more from the nation's no.1 hospital blog.
Complete our online appointment request form and receive an email response within 1 business day:
Request an Appointment
Contact us with Questions
Cancer Answer Line:
M-F 8 a.m. - 4:30 p.m. ET
Our New Home for Cancer Care
In a continued effort to provide the latest news and information to physicians outside of Cleveland Clinic, Taussig Cancer Institute produces Cancer Consult and our e-newsletter, Cancer eConsult.
Cancer Consult is a printed publication providing information from Cleveland Clinic cancer specialists about innovative research and diagnostic and management techniques. It is distributed twice a year.
To receive future copies of Cancer Consult, please email firstname.lastname@example.org.
Cancer eConsult is a physician e-newsletter focusing on innovation, research, clinical trials, case studies, medical breakthroughs and educational programs. It is distributed bi-monthly.
Our Cancer Care blog for physicians and healthcare professionals. Discover the latest cancer research insights, innovations and emerging advances to impact your practice.
Cancer Research Advances reports on leading-edge discoveries and activities by our staff that will impact the future of care. We offer insight into how these projects fit our overall cancer-fighting strategy.
This presentation by Alok Khorana, MD, details the prevalence, consequences, and costs of Venous Thromboembolism (VTE) and describes the importance of both predicting and preventing VTE in cancer.
This protocol from Principal Investigator Brian I. Rini, MD and his team details a clinical trial to characterize the clinical outcome of patients with metastatic renal cell carcinoma (RCC) who defer initial systemic treatment.
Speak with a cancer nurse specialist for appointment assistance and for answers to your questions about cancer locally at 216.444.7923 or toll-free 1.866.223.8100.
Monday through Friday from 8 a.m. – 4:30 p.m. (ET).
Resources for medical professionals
Search available cancer clinical trials by disease, hospital, phase or number.
Cleveland Clinic © 1995-2016. All Rights Reserved. 9500 Euclid Avenue, Cleveland, Ohio 44195 | 800.223.2273 | TTY 216.444.0261